Autopsy report · NCT04844073
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
Cause of deathFunding or business
“Sponsor decision based on limited anti-cancer activity of TAK-186.”
Life of this trial
- Ran for about 4 years 3 months before it stopped.
- 95 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Takeda
- Sponsor type
- Industry
- Conditions
- Squamous Cell Cancer of Head and Neck (SCCHN); Non-small Cell Lung Cancer (NSCLC); Colorectal Cancer
- Interventions
- TAK-186
- Participants
- 95
- Sites
- 27
- Countries
- Australia, South Korea, United Kingdom, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.